News

Although the number of fungal infections has fallen in the United States and other developed nations due to the ease of obtaining HIV testing and access to ART, the risk still exists.

Diagnostic methods make all the difference in efforts against antimicrobial resistance.

Researchers suggest the need to consider previous infection with dengue in the development of any new prophylactic modality.

A new review article shows that if a child has a serious reaction to a vaccine, the chances of it happening again are very small.

As the United States enters the final weeks of West Nile virus season, state health officials from around the country report several new deaths caused by the virus.

A relatively rare mosquito-borne virus has hit a couple of US states this summer, and it has health officials urging state residents to protect themselves against mosquito bites.

Although the recent measles outbreak in Minnesota has been declared to be over, its occurrence underscores the need to address the larger issue of vaccine uptake in the United States.

Potentially defective personal protection equipment, patients’ involvement in hand hygiene, probiotics that work against C. difficile, what makes delafloxacin unique, and a new discovery against the herpes virus make up the Top 5 articles for the month of August 2017.

In a recent article, researchers discuss common fungal respiratory diseases in non-immunocompromised patients.

A new study suggests that sexual transmission of Zika virus may create a higher risk for fetal disease than transmission via mosquito.

The National Institutes of Health has awarded a 4-year, $4.8 million grant to the University of Arizona to speed up the development of delta-CPS1, a vaccine candidate to fight valley fever.

The new test examines proteins and peptides in saliva using proteomics, the study of proteomes and their functions.

A new study suggested that neonatal sepsis, which kills 1 million infants around the world each year, may be prevented with synbiotic treatment.

NIH study sheds light on the mechanism behind increased cardiovascular risks for those living with HIV.

Stay up-to-date on the latest infectious disease news by checking out this snapshot of our top 5 articles of the week.

A new study is disputing previous findings that the Zika virus persists in semen for up to 188 days.

When it comes to cleaning products that work against Clostridium difficile, a new study has found that wipes are better than sprays.

The CDC shares ACIP’s recommendations regarding the prevention and control of seasonal influenza with vaccines for the 2017-2018 season.

Those US residents affected by Hurricane Harvey need to be mindful of rodent-borne infections that can spread from displaced rodents.

As Hurricane Harvey continues to dump heavy rains on Texas, health officials are urging residents to stay away from floodwater and get tetanus shots.

Living longer with HIV means that dying from cancer becomes more of a possibility.

Scientists from Northwestern Medicine use a novel approach to gain a better understanding of the HIV lifecycle.

A measles outbreak that affected 79 individuals in the state of Minnesota this spring and summer 2017 was recently declared “over” by the Minnesota Department of Health (MDH).

The FDA approves meropenem-vaborbactam (Vabomere) for the treatment of adult patients with complicated urinary tract infections, including those with pyelonephritis.

With federal and state officials rescuing Texas and Louisiana residents from the floodwaters of Hurricane Harvey, health experts are looking into the storm’s impact on mosquitoes carrying West Nile and Zika viruses.

Aetna, the third-largest insurer in the United States, inadvertently sent HIV-positive patients letters that revealed their HIV status through a large, clear window envelope.

The results of a new study from the United Kingdom reveal that oral prednisone had no effect on the severity and duration of symptoms in adult patients suffering from bronchitis.

Benznidazole has been granted accelerated approval by the US Food and Drug Administration for use in children aged 2 to 12 years with Chagas disease.